We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
-3.58%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$18.5B
AUM Growth
-$797M
(-4.1%)
Cap. Flow
+$398M
Cap. Flow
% of AUM
2.15%
Top 10 Holdings %
Top 10 Hldgs %
9.66%
Holding
1,697
New
297
Increased
468
Reduced
599
Closed
333
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$276M |
| 2 |
Meta Platforms (Facebook)
META
|
+$224M |
| 3 |
Microsoft
MSFT
|
+$177M |
| 4 |
Nike
NKE
|
+$133M |
| 5 |
Coca-Cola
KO
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$213M |
| 2 |
Apple
AAPL
|
+$185M |
| 3 |
PayPal
PYPL
|
+$169M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$104M |
| 5 |
Blackrock
BLK
|
+$95.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Healthcare | 12.99% |
| 3 | Consumer Discretionary | 11.59% |
| 4 | Financials | 10.5% |
| 5 | Industrials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Twist Bioscience
TWST
$7.86B
| $9.65M | 0.05% |
273,756
-126,700
| -32% | -$5.38M |
|
452
SLM Corp
SLM
$5.22B
| $9.63M | 0.05% |
688,690
+420,058
| +156% | +$6.51M |
|
453
Franco-Nevada
FNV
$44.7B
| $9.59M | 0.05% |
+80,223
| New | +$10.1M |
|
454
Sonos
SONO
$1.96B
| $9.58M | 0.05% |
689,144
+595,478
| +636% | +$10.6M |
|
455
Texas Instruments
TXN
$250B
| $9.57M | 0.05% |
61,824
-89,533
| -59% | -$15M |
|
456
EastGroup Properties
EGP
$11B
| $9.55M | 0.05% |
66,145
-7,190
| -10% | -$1.17M |
|
457
Axsome Therapeutics
AXSM
$11.2B
| $9.54M | 0.05% |
213,793
+101,384
| +90% | +$5.07M |
|
458
Pegasystems
PEGA
$5.51B
| $9.52M | 0.05% |
592,460
+295,820
| +100% | +$6.02M |
|
459
Parker-Hannifin
PH
$134B
| $9.49M | 0.05% |
39,166
-64,991
| -62% | -$17.6M |
|
|
EVBG
460
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $9.43M | 0.05% |
305,514
-187,974
| -38% | -$6.17M |
|
461
Sprout Social
SPT
$604M
| $9.39M | 0.05% |
154,745
-152,943
| -50% | -$9.19M |
|
462
Integra LifeSciences
IART
$1.42B
| $9.31M | 0.05% |
219,796
+86,663
| +65% | +$4.44M |
|
463
Brixmor Property Group
BRX
$9.21B
| $9.3M | 0.05% |
503,750
-261,880
| -34% | -$5.66M |
|
464
United Airlines
UAL
$41B
| $9.3M | 0.05% |
285,761
-2,017,285
| -88% | -$75M |
|
|
CTIC
465
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $9.2M | 0.05% |
1,580,934
+753,143
| +91% | +$4.69M |
|
|
CPRX
466
DELISTED
Catalyst Pharmaceutical
CPRX
| $9.2M | 0.05% |
+716,746
| New | +$8.49M |
|
467
Barclays
BCS
$94.6B
| $9.15M | 0.05% |
1,429,155
+884,578
| +162% | +$6.82M |
|
468
HEICO Corp
HEI
$51.9B
| $9.11M | 0.05% |
63,277
-103
| -0.2% | -$15.4K |
|
469
Braze
BRZE
$3.36B
| $9.08M | 0.05% |
260,707
+155,693
| +148% | +$6.57M |
|
470
Shutterstock
SSTK
$217M
| $9.08M | 0.05% |
180,957
-23,635
| -12% | -$1.36M |
|
471
Armstrong World Industries
AWI
$7.68B
| $9.06M | 0.05% |
114,384
+50,119
| +78% | +$4.24M |
|
472
MarketAxess Holdings
MKTX
$5.72B
| $9.05M | 0.05% |
40,669
+16,685
| +70% | +$4.28M |
|
473
Glaukos
GKOS
$11.2B
| $9.04M | 0.05% |
169,787
+47,838
| +39% | +$2.47M |
|
474
Ryan Specialty Holdings
RYAN
$11B
| $9.01M | 0.05% |
221,700
+29,740
| +15% | +$1.25M |
|
475
Kinder Morgan
KMI
$71.4B
| $8.98M | 0.05% |
+539,881
| New | +$9.6M |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, Voloridge Investment Management held 1,697 positions worth $18.5B, down 4.1% from $19.3B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Voloridge Investment Management's Q3 2022 filing shows 297 new, 468 increased, 599 reduced and 333 closed positions. Its largest new stake was Linde: 388,955 shares worth $105M. The largest sale was Tesla, an estimated $213M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Voloridge Investment Management's largest Q3 2022 buy was Linde: 388,955 shares worth $105M.
- Voloridge Investment Management added most to Adobe in Q3 2022, an estimated $276M increase.
- Voloridge Investment Management's biggest Q3 2022 reduction was Tesla, cutting an estimated $213M.
- Voloridge Investment Management fully exited Apple in Q3 2022, selling an estimated $185M.
- Voloridge Investment Management's ten largest holdings make up 9.7% of its $18.5B portfolio in Q3 2022.
- Voloridge Investment Management opened 297 new positions and closed 333 in Q3 2022.
- Voloridge Investment Management's portfolio value fell 4.1% quarter-over-quarter to $18.5B.
Based on Voloridge Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.